Performance
Ipamorelin
5 MG · Research Peptide
$45.00
A selective growth hormone secretagogue pentapeptide, examined in laboratory research on receptor-specific signaling.
- 5 mg lyophilized powder per vial
- ≥ 99% purity, HPLC verified
- Batch tested for identity and potency
- For laboratory research use only
View Ipamorelin batch Certificates of AnalysisIpamorelin research guideRP-HPLC purity standards guideMass spectrometry testing guideStorage and refrigeration guideReconstitution guideGlossary of analytical terms
Research use only. Not for human consumption.
What is Ipamorelin?
Ipamorelin is a synthetic 5-amino-acid pentapeptide studied in laboratory research as a selective growth hormone secretagogue receptor ligand. It is not approved by the FDA as a therapeutic drug.
| Sequence | Aib-His-D-2-Nal-D-Phe-Lys-NH2 |
|---|---|
| Length | 5 amino acids (C-terminal amide) |
| Molecular formula | C38H49N9O5 |
| Molecular weight | 711.9 g/mol (average) |
| CAS number | 170851-70-4 |
| Purity specification | ≥ 99.0% by RP-HPLC |
| Research status | Preclinical and in-vitro research compound. No FDA-approved indication; not an approved medicine in the United States. |
| Analytical methods | Reversed-phase HPLC (RP-HPLC) for purity and mass spectrometry (MS) for identity confirmation, reported per lot. |
| Available COA | Certificates of Analysis are published per lot in the Vector E Lab COA library as batches are released. View published certificates |
| Regulatory context | Supplied for Research Use Only (RUO) — in-vitro laboratory research and analytical testing by qualified personnel. Not for human or veterinary use, not for diagnostic procedures, and not a therapeutic product. |
| References |
Analytical specifications
| Purity (RP-HPLC) | ≥ 99.0% by reversed-phase HPLC |
|---|---|
| Fill quantity | 5 MG lyophilized powder per vial |
| Category | Performance |
| Intended use | Research Use Only (RUO) — in-vitro laboratory research |
Frequently asked questions
- What is Ipamorelin?
- Ipamorelin is a synthetic 5-amino-acid pentapeptide studied in laboratory research as a selective growth hormone secretagogue receptor ligand. It is not approved by the FDA as a therapeutic drug. Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2. Molecular weight: 711.9 g/mol (average). CAS number: 170851-70-4. Research status: Preclinical and in-vitro research compound. No FDA-approved indication; not an approved medicine in the United States. Analytical methods: Reversed-phase HPLC (RP-HPLC) for purity and mass spectrometry (MS) for identity confirmation, reported per lot.
- What is the purity of Ipamorelin?
- Ipamorelin is released at ≥ 99.0% purity as determined by reversed-phase HPLC (RP-HPLC). Purity is reported per lot on the batch Certificate of Analysis.
- Is a Certificate of Analysis available for Ipamorelin?
- Batch Certificates of Analysis for Vector E Lab research peptides are published in the COA library. Contact support with your lot number if a specific Ipamorelin certificate is not yet listed.
- How is Ipamorelin supplied?
- Each vial contains 5 MG of lyophilized powder, supplied in the Performance research category for in-vitro laboratory work.
- Can Ipamorelin be used in humans or animals?
- No. Ipamorelin is supplied strictly for Research Use Only (RUO) — in-vitro laboratory research and analytical testing by qualified laboratory personnel. It is not for human or veterinary use, diagnostic procedures, or therapeutic administration.
Related research peptides
